Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF + PCI-II Program James K. Chow , Akshay Bagai , Mary K. Tan , Bryan J. Har , Amelia M. C. Yip , Mario Paniagua , Basem Elbarouni , Kevin R. Bainey , Jean -Michel Paradis , Robert Maranda , Warren J. Cantor , Mark J. Eisenberg , Jean-Pierre Dery , Mina Madan , Tomas Cieza , Alexis Matteau , Sherryn Roth , Shahar Lavi , Anthony Glanz , Dongsheng Gao , Ravi Tahiliani , Robert C. Welsh , Hahn Hoe Kim , Simon D. Robinson , Benoit Daneault , Aun-Yeong Chong , Michel R. Le May , Vineeta Ahooja , Jean C. Gregoire , Pierre-Louis Nadeau , Zachary Laksman , Brettaa Heilbron , Derek Yung , Kunal Minhas , Ronald Bourgeois , Christopher B. Overgaard , Hamid Bonakdar , Giridhar Logsetty , Andrea J. Lavoie , Robert De LaRochelliere , Samer Mansour , Caroline Spindler , Andrew T. Yan , Shaun G. Goodman Journal of Cardiology（2023）
Key words
Atrial fibrillation, Percutaneous coronary intervention, Triple therapy, Dual pathway therapy, Direct oral anticoagulant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
